Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-006023
Filing Date
2025-08-18
Accepted
2025-08-18 16:48:39
Documents
80
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bglc_10q.htm   iXBRL 10-Q 1650855
2 NON‑QUALIFIED STOCK OPTION AGREEMENT bglc_ex108.htm EX-10.8 35748
3 CERTIFICATION bglc_ex311.htm EX-31.1 12583
4 CERTIFICATION bglc_ex312.htm EX-31.2 10242
5 CERTIFICATION bglc_ex321.htm EX-32.1 3478
6 CERTIFICATION bglc_ex322.htm EX-32.2 2806
  Complete submission text file 0001477932-25-006023.txt   7551682

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bglc-20250630.xsd EX-101.SCH 57064
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20250630_lab.xml EX-101.LAB 303733
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20250630_cal.xml EX-101.CAL 57853
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20250630_pre.xml EX-101.PRE 260403
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20250630_def.xml EX-101.DEF 128668
83 EXTRACTED XBRL INSTANCE DOCUMENT bglc_10q_htm.xml XML 1718411
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41750 | Film No.: 251228488
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)